Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 520 participants.
Also called NCT07908875
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 520 participants
- Registry
-
NCT07908875
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07908875. Randomized; single masking; primary purpose treatment. Start 2026-11-30 (anticipated); primary completion 2027-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
- Condition
- Ischemia Stroke
- Intervention (Drug)
- Atorvastatin
- Intervention (Drug)
- Hybutimibe 10mg QD
- Lead sponsor
- First Affiliated Hospital of Wannan Medical College
Record details
- Record id
cardio:ct-nct07908875- Content hash
7fff621de62c54faa0e868521638f7212663a793a022d7a0c84f4a82aaffca30